- Parkinson’s reversal? One drug brings dying brain cells back to life
Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and neuroprotective signals in a mouse model of genetic Parkinson’s. After three months on the LRRK2-blocking drug MLi-2, damaged circuits revived and early signs of neuronal recovery emerged, hinting that timely treatment could not only halt but reverse disease progression—and perhaps benefit other Parkinson’s forms.
- Feeling groggy? Life Kit has tips for optimal napping
Ever wake up from a nap feeling extra groggy? Naps can be beneficial for your mental and physical health - but there's a few things you need to know. NPR's Life Kit has tips for the optimal nap.
- AI spots deadly heart risk most doctors can't see
An advanced Johns Hopkins AI model called MAARS combs through underused heart MRI scans and complete medical records to spot hidden scar patterns that signal sudden cardiac death, dramatically outperforming current dice-roll clinical guidelines and promising to save lives while sparing patients unnecessary defibrillators.
- Even low levels of air pollution may quietly scar your heart, MRI study finds
Breathing polluted air—even at levels considered “safe”—may quietly damage your heart. A new study using advanced MRI scans found that people exposed to more air pollution showed early signs of scarring in their heart muscle, which can lead to heart failure over time. This damage showed up in both healthy individuals and people with heart conditions, and was especially noticeable in women, smokers, and those with high blood pressure.
- Sweet-smelling molecule halts therapy-resistant pancreatic cancer
A compound best known for giving almonds and apricots their aroma may be the key to defeating hard-to-kill cancer cells. Japanese researchers found that benzaldehyde can stop the shape-shifting ability of aggressive cancer cells, which lets them dodge treatments and spread. By targeting a specific protein interaction essential for cancer survival—without harming normal cells—benzaldehyde and its derivatives could form the basis of powerful new therapies, especially when combined with existing radiation or targeted treatments.
- Are you a glucose 'dipper'? Here's how to fix those blood sugar highs and lows
After a meal, some people experience high spikes in blood sugar followed by crashing lows. This can cause fatigue, anxiety and trigger overeating. Learning how to manage your blood sugar can help.
- GOP governors stay silent amid plans to slash Medicaid spending in their states
In 2017, when President Trump tried to repeal Obamacare and roll back Medicaid coverage, Republican governors rallied against it. Now, as Trump tries again to scale back Medicaid, they've gone quiet.
- This sun-powered sponge pulls drinking water straight from the ocean
In a leap toward sustainable desalination, researchers have created a solar-powered sponge-like aerogel that turns seawater into drinkable water using just sunlight and a plastic cover. Unlike previous materials, this new 3D-printed aerogel maintains its efficiency at larger sizes, solving a key scalability issue. In outdoor tests, it produced clean water directly from the ocean without any electricity, pointing to a future of low-cost, energy-free freshwater production.
- The fatal mutation that lets cancer outsmart the human immune system
Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers than our primate cousins. The change affects a protein used by immune cells to kill tumors—except in humans, it’s vulnerable to being shut down by an enzyme that tumors release. This flaw may be one reason treatments like CAR-T don’t work as well on solid tumors. The surprising twist? That mutation might have helped our brains grow larger over time. Now, researchers are exploring ways to block the enzyme and give our immune system its power back.
- Deafness reversed: Single injection brings hearing back within weeks
A cutting-edge gene therapy has significantly restored hearing in children and adults with congenital deafness, showing dramatic results just one month after a single injection. Researchers used a virus to deliver a healthy copy of the OTOF gene into the inner ear, improving auditory function across all ten participants in the study. The therapy worked best in young children but still benefited adults, with one 7-year-old girl regaining almost full hearing. Even more exciting: this is just the start, as scientists now aim to target other genes that cause more common forms of deafness.